drug protocol number

F3Z-MC-B01

drug sponsor

Eli Lilly

drug study

N/A

drug trial site

International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif)

drug status

Ongoing

drug phase